During the pioglitazone phase , the mean peak plasma repaglinide concentration ( C ( max ) ) and the total area under the concentration-time curve [ AUC ( 0-infinity ) ] of repaglinide were 100 % ( range 53-157 % , P = 0.99 ) and 90 % ( range 63-120 % , P = 0.22 ) , respectively , of those during the placebo phase .
